<DOC>
	<DOCNO>NCT02636517</DOCNO>
	<brief_summary>Fecal Microbiota Transplant ( FMT ) pediatric patient recurrent C. Difficile without Inflammatory Bowel Disease ( IBD ) The aim study determine safety efficacy FMT treatment pediatric patient recurrent moderate severe C. Difficile without ( observational study ) ( clinical trial ) Inflammatory Bowel Disease determine effect FMT gut microbiota use 454 pyrosequencing transplantation patient .</brief_summary>
	<brief_title>Fecal Microbiome Transplant</brief_title>
	<detailed_description />
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<criteria>1 . Diagnosis Inflammatory Bowel Disease colonoscopy , radiographic clinic measure , per standard protocol . 2 . Age â‰¥ 3 year old . 3 . Recurrent C. difficile Moderate Severe C. difficile . 4 . Satisfactory completion medical interview physical exam conduct study team member 5 . Participants must 3 21 year age ( inclusive ) 6 . Negative serologic test document baseline status within one month prior FMT , include , limited : HIV 1 &amp; 2 , Hepatitis A total , Hepatitis B surface Ag , surface Ab core Ab , Hepatitis C Ab , rapid plasma reagin ( RPR ) 7 . Signed informed consent form , assent ( applicable ) 1 . Patients &lt; 3 year old 2 . Patients comorbid intestinal infectious process 3 . Patients exclude immunosuppressive therapy within 2 week FMT . Clinical care adjust order meet criterion study . 4 . Patients currently receive chemotherapy 5 . Recipients history severe ( anaphylactic ) food allergy 6 . If female , participant childbearing potential ( female age 11 old already begin menstruate ) require urine pregnancy test day FMT procedure . Patients pregnant enrol .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Fecal Microbiota transplant</keyword>
</DOC>